Publications by authors named "Enora Ferron"

Claim this Profile
L
Leveraging the heterogeneity of the NK cell repertoire for the development of immunotherapies for acute leukemia.
Enora Ferron, Maxime Jullien, Katia Gagne, Christelle Retière

J Transl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-AML activity.
Maxime Jullien, Enora Ferron, Catherine Willem, Gaelle David, Nolwenn Legrand

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Interactions Between NK Cells and Acute Leukemic Cells: KIR2DL5 Drastically Limits NK Cell Responses.
Enora Ferron, Maxime Jullien, Martin Braud, Gaëlle David, Cynthia Fourgeux

J Clin Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifactorial determinants of NK cell repertoire organization: insights into age, sex, KIR genotype, HLA typing, and CMV influence.
Enora Ferron, Gaëlle David, Catherine Willem, Nolwenn Legrand, Perla Salameh

Front Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Expressed Donor KIR3DL1 Alleles May Represent a Risk Factor for Relapse after T-Replete Haploidentical Hematopoietic Stem Cell Transplantation.
Nolwenn Legrand, Perla Salameh, Maxime Jullien, Patrice Chevallier, Enora Ferron

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis